Filing Flows › Staar Surgical (STAA) › Takeover & LBO
Is Staar Surgical (STAA) a takeover target?
A leveraged buyout does not work for Staar Surgical on its latest figures: its EBITDA margin is only 2.8% ($9.2M on revenue of $328M), too thin to carry buyout debt. Historically 5.1% of companies with its figures were bought within a year (1.02× the average).
Why a leveraged buyout does not fit
Staar Surgical kept 2.8% of its revenue as EBITDA over the last 12 months ($9.2M on $328M). A margin that thin cannot carry the debt a leveraged buyout needs — a small dip in sales would leave nothing for interest — so the model gives no buyout price.
What a takeover could cost
Takeovers in its sector paid a median premium of 35% over the share price before the deal (the middle half 22% to 45%), according to the 15 merger proxies and tender-offer responses on EDGAR that state a premium. At the median, Staar Surgical would cost about $29.25 a share, $1.5B for all its shares.
| Premium | % | Price a share | All shares |
|---|---|---|---|
| Low end (a quarter of deals paid less) | 22% | $26.44 | $1.4B |
| Median | 35% | $29.25 | $1.5B |
| High end (a quarter paid more) | 45% | $31.42 | $1.6B |
The odds, from history
Historically 5.1% of companies with its figures were bought within a year (1.02× the average). Its figures put it in decile 6 of 10 (10 = the most likely to be bought). The odds come from a model of every merger proxy, tender-offer response and going-private statement filed on EDGAR since 2011, set against each company's size, margins, debt, cash flow and growth the year before.
Staar Surgical's latest quarter
Staar Surgical, Q3 2026: revenue $83.4M (-12% year over year), operating margin 6.5%, net earnings $5.6M, operating cash flow $27.3M. The chart follows the revenue to costs, profit and cash.
Questions
Is Staar Surgical being acquired?
No headline, 8-K or 13D about a sale is on file in the last year.
Could private equity buy Staar Surgical?
A leveraged buyout does not work for Staar Surgical on its latest figures: its EBITDA margin is only 2.8% ($9.2M on revenue of $328M), too thin to carry buyout debt. A margin that thin leaves almost nothing to pay interest with, so buyout debt does not fit.
What would a takeover of Staar Surgical cost?
Takeovers in its sector paid a median premium of 35% over the share price before the deal (the middle half 22% to 45%), according to the 15 merger proxies and tender-offer responses on EDGAR that state a premium. At the median, Staar Surgical would cost about $29.25 a share, $1.5B for all its shares.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.